テキサスにおける円形脱毛症の臨床試験
テキサス内の拠点で、円形脱毛症に関する7件の研究が参加者を募集しています。
テキサス内の都市
公式研究テキスト（英語）
A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
- 3A Research - East location /ID# 283404, El Paso
- Texas Dermatology and Laser Specialists /ID# 282813, San Antonio
被験者募集中第3相
6歳〜17歳 · 全性別 · 2026/10/02更新 · NCT07772492A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
- Texas Dermatology and Laser Specialists - San Antonio - South New Braunfels Avenue, San Antonio
被験者募集中第2相
18歳〜50歳 · 全性別 · 2026/09/22更新 · NCT07533006A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
- The University of Texas Health Science Center at Houston, Bellaire
- Center for Clinical Studies, Houston
- Center for Clinical Studies - Clear Lake, Webster
被験者募集中第3相
12歳以上 · 全性別 · 2026/09/18更新 · NCT06873945A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
- Center for Clinical Studies, LTD. LLP, Houston
- Texas Dermatology and Laser Specialists, San Antonio
被験者募集中第3相
12歳以上 · 全性別 · 2026/09/10更新 · NCT07733765A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
- Arlington Research Center, Inc /ID# 258028, Arlington
- Bellaire Dermatology Associates /ID# 259360, Bellaire
- Dfw Clinical Trials /ID# 284604, Carrollton
- 他5件
被験者募集中第3相
12歳〜63歳 · 全性別 · 2026/08/03更新 · NCT06012240A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
- 3A Research, El Paso
- Texas Dermatology and Laser Specialists, San Antonio
被験者募集中第3相
6歳〜14歳 · 全性別 · 2026/04/28更新 · NCT07029828Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
- Dermatology Treatment And Research Center - Dallas, Dallas
- North Texas Center For Clinical Research, Frisco
- Austin Institute For Clinical Research Inc., Pflugerville
- 他1件
被験者募集中第3相
12歳〜17歳 · 全性別 · 2026/01/28更新 · NCT07133308ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。